2011: A1-001. ABC Proteins and Ciprofloxacin Resistance in Streptococcus pneumoniae

134 Pages·2012·0.79 MB·English

111th American Society for

Microbiology General

Meeting 2011

Abstracts

New Orleans, Louisiana, USA

21-24 May 2011

V olume 1 of 4

ISBN: 978-1-61839-269-5
Printed from e-media with permission by:

Curran Associates, Inc.
57 Morehouse Lane
Red Hook, NY 12571

Some format issues inherent in the e-media version may also appear in this print version.

Copyright© (2011) by the American Society for Microbiology
All rights reserved.

Printed by Curran Associates, Inc. (2011)

For permission requests, please contact the American Society for Microbiology
at the address below.

ASM Press
P.O. Box 605
Herndon, VA 20172
USA

Phone: [phone] or [phone]
Fax: [phone]

[email protected]

Additional copies of this publication are available from:

Curran Associates, Inc.
57 Morehouse Lane
Red Hook, NY 12571 USA
Phone: [phone]
Fax: [phone]
Email: [email protected]
Web: www.proceedings.com
TABLE OF CONTENTS

VOLUME 1

CATEGORY A – ANTIMICROBIAL CHEMOTHERAPY

MECHANISMS OF RESISTANCE IN GRAM POSITIVE BACTERIA (DIVISION A)

ABC PROTEINS AND CIPROFLOXACIN RESISTANCE IN STREPTOCOCCUS PNEUMONIAE.................................................1
A. Lupien, D. S. Billal, H. Gingras, G. G. Zhanel, P. Leprohon, M. Ouellette
MUTATION IN A PUTATIVE IRON TRANSPORTER IN PENICILLIN RESISTANT STREPTOCOCCUS
PNEUMONIAE..................................................................................................................................................................................................2
F. Fani, D. Légaré, M. Ouellette
EVOLUTION AND CHARACTERIZATION OF BACILLUS SUBTILIS MUTANTS RESISTANT TO CELL
WALL ANTIBIOTICS......................................................................................................................................................................................3
Y. H. Lee, J. D. Helmann
ANALYSIS OF LINEZOLID RESISTANCE MECHANISMS AND EPIDEMIOLOGY OF CFR-PRODUCING
STRAINS IN THE UNITED STATES.............................................................................................................................................................4
R. E. Mendes, L. M. Deshpande, M. Castanheira, R. N. Jones
POSSIBLE MECHANISMS OF CELL WALL THICKNESS INDUCED IN STAPHYLOCOCCUS AUREUS BY
QUATERNARY AMMONIUM COMPOUNDS OF ANTISEPTIC AGENTS..........................................................................................6
M. Kawai, S. Yamada, K. Morikawa, J. Yamagishi
A STRESS INDUCIBLE PHEROMONE MEDIATES THE FORMATION OF NON-INHERITED ANTIBIOTIC
TOLERANCE IN STREPTOCOCCUS MUTANS........................................................................................................................................7
V. Leung, C. M. Levesque
MOLECULAR MECHANISMS OF RESISTANCE TO MACROLIDES IN INVASIVE STREPTOCOCCUS
PNEUMONIAE SEROTYPES AT A TERTIARY CARE CENTER IN LEBANON................................................................................8
N. Taha, G. F. Araj, G. Dbaibo, R. Wakim, S. Kanj, Z. Kanafani, M. T. Khairallah, A. Sabra, F. Nassar, G. M. Matar
A SURVEY OF TN916 FAMILY TRANSPOSONS IN ORAL STREPTOCOCCUS SPP. SHOWS THAT THESE
ELEMENTS CONTAIN A RANGE OF DIFFERENT ANTIBIOTIC AND ANTISEPTIC RESISTANCE GENES...........................9
L. Ciric, M. Ellatif, P. Sharma, P. Mullany, A. P. Roberts
A MERR-LIKE TRANSCRIPTIONAL REGULATOR IS ESSENTIAL FOR P. AERUGINOSA BIOFILM
RESISTANCE...................................................................................................................................................................................................10
S. Liao, K. Sauer
DIFFERENTIAL INDUCTION OF BLASME-1 AND AMPC IN A CLINICAL ISOLATE OF SERRATIA
MARCESCENS AND ITS MUTANT............................................................................................................................................................11
A. L. Roth, S. J. Cavalieri, G. L. Gorby, N. D. Hanson
CLASS 2 INTEGRONS DISSEMINATION AMONG MULTIDRUG RESISTANCE (MDR) CLONES OF
ACINETOBACTER BAUMANNII (AB) CIRCULATING IN THE SOUTH CONE.............................................................................12
M. S. Ramirez, A. M. Morales, E. Vilacoba, M. Nardelli, C. Marquez
CLINICAL AND MOLECULAR EPIDEMIOLOGY OF ESBL PRODUCING KLEBSIELLA PNEUMONIAE
AND ESCHERICHIA COLI IN THE NAGASAKI UNIVERSITY HOSPITAL....................................................................................13
Y. Harada, K. Yanagihara, N. Araki, K. Yamada, Y. Morinaga, K. Izumikawa, M. Seki, H. Kakeya, Y. Yamamoto, Y. Yamada, S.
Kohno, S. Kamihira
ANTIBIOTIC RESISTANT ESCHERICHIA COLI ISOLATED FROM SAMPLES OF PAEDIATRICS........................................14
I. P. Udoh, C. I. Eleazar, U. C. Ozumba
AN ENGINEERED SUBTILISIN SERINE PROTEASE CLEAVES THE BOTULINUM TOXIN LIGHT CHAIN
AT A SPECIFIC LOCATION TO ELIMINATE TOXIN ACTIVITY.....................................................................................................15
T. Brown, J. Daniel, E. Brueggemann, M. Hale, H. Hines, A. Ahmed, B. Stiles, B. Purcell, P. Bryan, D. A. Rozak

RESISTANCE IN GRAM POSITIVE BACTERIA (DIVISION A)

DECLINING MRSA AND FLUOROQUINOLONE RESISTANCE RATES AMONG S. AUREUS (SA) IN THE
USA: REPORT FROM THE SENTRY ANTIMICROBIAL SURVEILLANCE PROGRAM (2000-2009).........................................16
R. N. Jones, M. Castanheira, G. J. Moet, M. J. Janechek
PENICILLIN SUSCEPTIBILITY AND MACROLIDE-LINCOSAMIDE-STREPTOGRAMIN B RESISTANCE
IN GROUP B STREPTOCOCCUS ISOLATES FROM A CANADIAN HOSPITAL............................................................................17
K. E. Sherman, S. Whitehead, K. Wagner, E. Blondel-Hill, N. Cheeptham
POINT IN TIME ANTIMICROBIAL RESISTANCE STATUS OF S. AUERUS IN KARACHI, PAKISTAN..................................18
F. E. Abdullah, A. R. Bhutto, R. Jawed, N. Farhan, Y. Taj, S. U. Kazmi
STAPHYLOCOCCUS AUREUS BACTEREMIA IN A COMMUNITY HOSPITAL 2008-2009:
SUSCEPTIBILITY TO CEFTOBIPROLE AND OTHER VANCOMYCIN ALTERNATIVES..........................................................19
H. H. Liu, M. Scutti, V. Khetarpaul, L. Cushinotto, O. Giger
IN VITRO ACTIVITY OF RETAPAMULIN AGAINST STAPHYLOCOCCUS AUREUS AND
STREPTOCOCCUS PYOGENES ISOLATED FROM SKIN AND SKIN STRUCTURE INFECTIONS..........................................20
J. A. Karlowsky, S. Bouchillon, M. Hackel, N. E. Scangarella-Oman
THE USEFULNESS OF ANTI-MICROBIAL PEPTIDES INHIBITION OF STREPTOCOCCAL GROWTH................................22
R. D. Harris, V. A. Dennis, S. R. Singh, M. Baker, P. Subbarayan, E. Nyairo, M. T. Coats
IN VITRO ANTIMICROBIAL SUSCEPTIBILITY OF SHOULDER IMPLANT-ASSOCIATED BACTERIA...............................23
M. J. Karau, S. M. Schmidt, J. M. Steckelberg, R. Patel
EPIDEMIOLOGY OF HUMAN ISOLATED LACTOBACILLUS SPP. AND THEIR ANTIBIOTIC
SUSCEPTIBILITIES IN ITALY....................................................................................................................................................................24
P. M. Furneri, M. C. Scuderi, V. Giummarra, G. Petronio Petronio, C. Ferranti, L. S. Roccasalva
CLINDAMYCIN RESISTANCE RATES OF CA-MRSA STRAINS IN NEWARK, NJ, USA..............................................................25
H. R. Jimenez, Y. Sultana, C. Linson, N. Chamas, J. Slim
CURRENT STATUS OF MULTI DRUG RESISTANT BACTERIA AND THEIR ANTIBIOGRAM. A STUDY
AT A TERTIARY CARE HOSPITAL OF PAKISTAN..............................................................................................................................26
F. Kaleem, J. Usman
SURVEILLANCE OF LINEZOLID ACTIVITY AGAINST STAPHYLOCOCCI IN THE UNITED STATES
(USA; 2010).......................................................................................................................................................................................................27
R. N. Jones, J. E. Ross, M. Castanheira, R. E. Mendes, D. J. Farrell
CHARACTERIZATION OF C. PARAPSILOSIS - S. AUREUS POLYMICROBIAL BIOFILMS AND
EVALUATION OF OPTIMAL THERAPY.................................................................................................................................................28
M. M. Harriott, D. A. Vager, J. A. Vazquez
A MULTI-PHASIC MICROBIAL ECOLOGY ASSESSMENT ON ENVIRONMENTAL SAFETY OF
GENETICALLY MODIFIED CORYNEBACTERIAUM GLUTAMICUM ATCC13032.....................................................................29
I. Han, J. Han, S-B. Kim, J. Park
EMERGENCE OF MULTIDRUG RESISTANT STRAINS OF CLOSTRIDIUM DIFFICILE...........................................................30
I. A. Tickler, D. H. Persing, F. C. Tenover

RESISTANCE IN GRAM NEGATIVE BACTERIA (DIVISION A)

ANTIMICROBIAL SUSCEPTIBILITY PROFILE OF ACINETOBACTER BAUMANNII ISOLATES IN JAPAN.......................31
F. Ikeda, E. Fujihara, T. Iyoda, M. Kaneoka, A. Amano, K. Matsuzaki, T. Yamashita, T. Saika, M. Hasegawa, A. Kanayama, I.
Kobayashi
DETECTION OF BLA IN A CLINICAL ISOLATE OF PROVIDENCIA STUARTII FROM A MEDICAL
NDM1
FACILITY IN AFGHANISTAN....................................................................................................................................................................32
P. T. McGann, D. V. Zurawski, Y. Si, P. E. Waterman, A. Summers, B. C. Kirkup, C. Z. Li, E. P. Lesho, D. W. Craft
PREVALENCE OF MULTIDRUG-RESISTANT GRAM-NEGATIVE RODS (MDR-GNRS) AMONG URINARY
COMMUNITY ISOLATES, AND IMPACT OF PATIENT AGE ON MDR-GNR PREVALENCE AND
RESISTANCE RATES....................................................................................................................................................................................33
S. E. Farhat, I. Coelho, G. Lim, B. Shingala, D. Shah, B. Premraj, A. E. Simor
SCREENING THE LITTLE BIG HORN RIVER FOR TETRACYCLINE RESISTANCE GENES...................................................34
A. Lafountain, S. Racki, H. Alweis, M. Schvetz, C. Cummins, A. Lopez, L. Holmberg, B. King, K. Kaercher, C. H. Hunnes
SALMON AQUACULTURE AND PLASMID-MEDIATED QUINOLONE RESISTANCE (PMQR) IN
BACTERIA.......................................................................................................................................................................................................35
A. Tomova, L. Ivanova, A. Buschmann, M. Rioseco, F. Cabello
FISH FARMS AS POTENTIAL RESERVOIRS FOR PLASMID-MEDIATED QUINOLONE RESISTANCE
(PMQR) GENES IN TURKEY.......................................................................................................................................................................36
Z. Gulay, M. Bicmen, M. Bagsever, N. Bizsel, C. K. Bizsel
IN VITRO ACTIVITY OF FOSFOMYCIN AGAINST ESBL - PRODUCING E. COLI FROM COMMUNITY -
ADQUIRED UTIS IN MEXICO....................................................................................................................................................................37
C. Giraud, R. Hernandez-Mata, S. Ruiz-Rodriguez
PREVALENCE OF EXTENDED-SPECTRUM β-LACTAMASE PRODUCING PSEUDOMONAS
AERUGINOSA IN SOUTHWESTERN NIGERIAN HOSPITALS..........................................................................................................38
B. T. A. Odumosu, B. C. A. Adeniyi, O. O. Soge, H. O. Dada-Adegbola
ANTIMICROBIAL RESISTANCE OF CLINICAL SHIGA TOXIN-PRODUCING ESCHERICHIA COLI
ISOLATES ORIGINATING FROM BRITISH COLUMBIA, CANADA................................................................................................39
L. R. Mesak, H. Xu, L. Hoang, K. J. Allen
EMERGENCE OF MULTIDRUG HYPERSUSCEPTIBILITY IN DORIPENEM (DOR) AND MEROPENEM
(MER) SELECTED MUTANTS OF PSEUDOMONAS AERUGINOSA (PA) COLLECTED FROM CYSTIC
FIBROSIS (CF) PATIENTS...........................................................................................................................................................................40
R. C. Fowler, P. D. Lister, N. D. Hanson
NOVEL CLASS 3 INTEGRON IN AN ACINETOBACTER JOHNSONII ISOLATE..........................................................................41
O. Barraud, T. Stalder, L. Melayers, C. Dagot, M-C. Ploy
KLEBSIELLA PNEUMONIAE CEPHALOSPORIN AND CARBAPENEM RESISTANCE RISING RAPIDLY
AMONG ICU BLOODSTREAM ISOLATES IN THE US.........................................................................................................................42
R. M. Mera, L. A. Miller, H. A. Madsen, D. F. Sahm
A METHOD FOR THE ENRICHMENT AND ISOLATION OF PSEUDOMONAS AERUGINOSA PERSISTER
CELLS...............................................................................................................................................................................................................43
J. M. Manson, L. R. Mulcahy, K. Lewis
ANTIBIOTIC RESISTANCE IN KLEBSIELLA PNEUMONIAE FROM AQUATIC ENVIRONMENTS.......................................44
C. Abundis, L. Mota-Bravo
CRYSTAL STRUCTURES OF THE CUSA EFFLUX PUMP SUGGEST METHIONINE-MEDIATED METAL
TRANSPORT....................................................................................................................................................................................................45
E. W. Yu
EFFECT OF THE RECENT CLINICAL AND LABORATORY STANDARDS INSTITUTE (CLSI)
BREAKPOINT CHANGES ON RESISTANCE RATES IN ESCHERICHIA COLI AND KLEBSIELLA
PNEUMONIAE IN TAIWAN.........................................................................................................................................................................46
P-C. Chen, H-Y. Wang, J-F. Lai, Y-R. Shiau, I-W. Huang, M-C. Tan, T-L. Lauderdale

MECHANISMS OF RESISTANCE IN GRAM NEGATIVE BACTERIA (DIVISION A)

CORRELATING CHANGES IN STRUCTURE AND FUNCTION OF BACTEROIDES
THETAIOTAOMICRON TETX2 TO FITNESS DURING ADAPTATION TO MINOCYCLINE.....................................................48
Y. Shamoo, K. Walkiewicz, M. Davlieva, C. Sun, M. I. Pena, K. Lau
PSEUDOMONAS AERUGINOSA PERSISTENCE TO FLUOROQUINOLONES DEPENDS ON CELL-CELL
RECOGNITION...............................................................................................................................................................................................49
M. Fauvart, V. N. De Groote, V. R. Liebens, J. Michiels
ANALYSIS OF ANTIMICROBIAL RESISTANCE GENES AND PLASMIDS FROM COMMENSAL
ESCHERICHIA COLI....................................................................................................................................................................................50
R. L. Lindsey, J. G. Frye, S. M. Thitaram, P. J. Fedorka-Cray, M. D. Englen
IN-VIVO DEVELOPMENT OF HIGH-LEVEL CARBAPENEM RESISTANCE IN AN ENTEROBACTER
AEROGENES ISOLATE: CONTRIBUTION OF PORINS, β-LACTAMASES AND EFFLUX PUMPS...........................................51
N. Gordon, M. Hornsey, D. Wareham
INVESTIGATING THE CONTRIBUTION OF THE POXAB OPERON TO β-LACTAM RESISTANCE IN
PSEUDOMONAS AERUGINOSA.................................................................................................................................................................52
D. Zincke, D. Balasubramanian, L. Schneper, K. Mathee
THE CARBON SOURCE INFLUENCES THE EFFLUX-MEDIATED ANTIMICROBIAL RESISTANCE IN
BOTH GRAM NEGATIVE AND GRAM POSITIVE BACTERIA..........................................................................................................53
N. Villagra, J. Fuentes, M. Jofré, G. Mora
CONTRIBUTION OF AN EFFLUX-PUMP (ACRAB) IN CARBAPENEM SUSCEPTIBILITY CAUSED BY
KLEBSIELLA PNEUMONIA CARBAPENEMASE-ENCODING GENE..............................................................................................54
B. Marmol, D. Kwon
ANTIMICROBIAL AND TOXIC METALS SUSCEPTIBILITY PATTERNS OF CLINICALLY RELEVANT
ENTEROBACTERIA ISOLATED FROM AQUACULTURE SYSTEMS..............................................................................................55
J. A. Resende, T. L. R. Oliveira, S. O. Fortunato, M. B. Campos, C. M. Coelho, D. E. Cesar, V. L. Silva, C. G. Diniz
CHANGING PLASMID TYPES RESPONSIBLE FOR EXTENDED SPECTRUM CEPHALOSPORIN
RESISTANCE IN ESCHERICHIA COLI O157:H7 IN THE UNITED STATES, 1996-2009...............................................................56
J. P. Folster, G. Pecic, R. Rickert, A. Carattoli, J. Whichard
PHENOTYPIC AND GENOTYPIC CHARACTERIZATION OF KPC-β-LACTAMASE-PRODUCING
ESCHERICHIA COLI AND KLEBSIELLA PNEUMONIAE ISOLATES FROM INDIANA HOSPITALS.....................................57
L. Wang, C. M. Orzech, J. P. Astin, W. Dong, J. Q. Summerton, N. G. Magill, G. A. Denys, K. Bush, R. M. Lee
STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF SUBSTRATE SPECIFICITY
DETERMINING RESIDUES IN CTX-M-14................................................................................................................................................58
A. M. Cardenas, L. B. Horton, N. G. Brown, T. G. Palzkill
PHENOTYPIC AND GENOTYPIC CHARACTERIZATION OF CTX-M-14 AND CTX-M-15 BETA-
LACTAMASES IN CLINICAL ISOLATES FROM INDIANA................................................................................................................59
W. Dong, L. Wang, C. M. Orzech, N. G. Magill, G. A. Denys, K. Bush, R. M. Lee
FUNCTIONAL ASSEMBLY OF THE ACRAB-TOLC MULTIDRUG EFFLUX PUMP.....................................................................60
J. W. Weeks, R. Misra
MUTAGENESIS OF CMY-2 β-LACTAMASE (BL)AT POSITION 221.................................................................................................61
M. Li, B. Conklin, M. J. Skalweit
CHARACTERIZATION OF TISB, SMALL MEMBRANE PEPTIDE INVOLVED IN PERSISTER
FORMATION IN ESCHERICHIA COLI....................................................................................................................................................62
R. Ortenberg, P. Gurnev, S. Bezrukov, K. Lewis
EFFECT OF N152G SUBSTITUTION ON CMY-2 β-LACTAMASE ACTIVITY AND INHIBITION..............................................63
M. Li, B. Conklin, R. A. Bonomo, M. J. Skalweit
PROTEOMIC ANALYSIS OF PSEUDOMONAS AERUGINOSA REVEALS AN EXTENSIVE AMPR
REGULON........................................................................................................................................................................................................64
S. K. Murugapiran, L. Schneper, M. Merighi, D. Balasubramanian, D. Sarracino, S. Lory, K. Mathee
MOLECULAR CHARACTERIZATION OF HIGH-LEVEL CEFTAZIDIME RESISTANCE IN CLINICAL
ISOLATES OF BURKHOLDERIA PSEUDOMALLEI FROM AUSTRALIA.......................................................................................65
D. S. Sarovich, E. P. Price, J. M. Cook, A. T. Vonschulze, L. M. Watson, L. J. Richardson, A. Tuanyok, M. Mayo, T. Pearson, B. J.
Currie, P. Keim, D. M. Wagner
A PSEUDOMONAS AERUGINOSA CLINICAL ISOLATE WITH ANTIBIOTIC RESISTANCE PROMOTED
BY THE SOS RESPONSE IN A PATIENT..................................................................................................................................................66
D. Hocquet, C. Llanes, M. Thouverez, H. Kulasekara, F. Legrand, X. Bertrand, P. Plésiat, D. Mazel, S. Miller
OPTIMIZING ANTIMICROBIAL PEPTIDES AS BROAD SPECTRUM COUNTERMEASURES..................................................67
M. A. Fox, J. E. Thwaite, D. O. Ulaeto, H. S. Atkins
A NOVEL SOXS MUTATION ASSOCIATED WITH MULTIDRUG RESISTANCE IN FLUOROQUINOLONE
RESISTANT ESCHERICHIA COLI............................................................................................................................................................68
S. Aly, N. Debavalya, O. Oryazabal, S-J. Suh, D. Boothe
ANTIMICROBIAL PEPTIDE RESISTANCE IN ENTERIC BACTERIA.............................................................................................69
N. Weatherspoon-Griffin, G. Zhao, Y. Shi

EXPERIMENTAL AND CLINICAL PHARMACOLOGY AND THERAPEUTICS (DIVISION A)

NOVEL ANTIBACTERIAL CHITOSAN DERIVATIVES WITH RESIDUAL ACTIVITY REDUCE MULTI-
DRUG RESISTANT BIOFILMS AND REMOVE BACTERIA FROM ABRADED SKIN...................................................................70
S. Townsend, J. Uhrig, S. Ryan, M. C. Perez, S. Baker, W. Wiesmann
ANTIMICROBIAL SUSCEPTIBILITY PROFILE OF PSEUDOMONAS AERUGINOSA ISOLATES FROM
BLOOD STREAM INFECTIONS COMPARED TO NIDUS OF INFECTION......................................................................................71
F. Ikeda, E. Fujihara, A. Amano, M. Kaneoka, K. Matsuzaki, T. Saika, T. Yamashita, M. Hasegawa, A. Kanamaya, I. Kobayashi
CONSTANT AND EXPONENTIAL EXPOSURE OF MATURE CANDIDA BIOFILM TO AMPHOTERCIN B...........................72
A. Khalifa, N. Khardori, K. Abou-Aisha, M. El-Azizi
IN VITRO COMBINATION OF METALLI SILVER NANOPARTICLES WITH BLUE LIGHT AGAINST THE
BIOFILM OF PSEUDOMONAS AERUGINOSA ON BIOPOLYMERIC DISC MODEL...................................................................73
S. A. Nour El Din, T. A. El Tayeb, K. Abou Aisha, M. El Azizi
IDENTIFICATION OF NOVEL HOST DEFENSE PROTEIN MIMICS FOR TREATMENT OF ORAL
CANDIDIASIS..................................................................................................................................................................................................74
K. B. Freeman, R. W. Scott, C. E. Budu, M. Patel, G. Diamond
CANDIDA ALBICANS BIOFILM CHIP (CABCHIP) FOR ULTRA HIGH-THROUGHPUT DRUG
DISCOVERY....................................................................................................................................................................................................75
A. Srinivasan, C. G. Pierce, J. L. Lopez Ribot, A. K. Ramasubramanian
THE EFFECTS OF THE PHOTOSENSITIZER PHLOXINE B AT VARIOUS CONCENTRATIONS ON
CAPSULE-PRODUCING STRAINS OF STAPHYLOCOCCUS AUREUS AND KLEBSIELLA PNEUMONIAE..........................76
D. Ingram, M. Ingram, B. Blair
NEW DRUG TO COMBAT MULTIDRUG-RESISTANT GRAM-NEGATIVE BACTERIA..............................................................77
K. M. Carlson, G. Cheng, A. Chou, R. L. Atmar, R. J. Hamill, Y. Song, L. Zechiedrich
RAT PLASMA AND BONE CONCENTRATIONS OF BT2-PEG2-VANCOMYCIN AND VANCOMYCIN VIA
INTRAPERITONEAL ADMINISTRATION...............................................................................................................................................78
S. M. Schmidt, Z. F. Albayati, M. J. Karau, J. M. Steckelberg, M. Sunkara, A. Morris, K. E. Merten, P. A. Crooks, R. Patel
DUAL MECHANISMS OF ACTION OF THE OLIGO-ACYL LYSYL ANTI-MICROBIAL PEPTIDE C K-2β
12 12
AGAINST HELICOBACTER PYLORI.......................................................................................................................................................79
M. O. Makobongo, H. Gancz, B. M. Carpenter, D. McDaniel, D. S. Merrell
IN VIVO EFFICACY OF BIAPENEM IN A MURINE MODEL MIMICKING VENTILATOR-ASSOCIATED
PNEUMONIA WITH PSEUDOMONAS AERUGINOSA..........................................................................................................................80
K. Yamada, K. Yanagihara, N. Araki, Y. Harada, Y. Morinaga, K. Izumikawa, M. Seki, H. Kakeya, Y. Yamamoto, Y. Yamada, S.
Kamihira, S. Kohno
EVALUATION OF ANTIMICROBIAL TREATMENT OF ESCHERICHIA COLI O157:H7 IN VITRO AND IN
A MOUSE MODEL OF INFECTION...........................................................................................................................................................81
E. A. Rahal, N. Kazzi, A. M. Abdelnoor, G. M. Matar
IN VIVO PROTECTIVE EFFICACY OF A PSEUDOMONAS BACTERIOPHAGE...........................................................................82
B. R. Tiwari, M. Rahman, S. Kim, J. Kim
NOVEL BACTERIOPHAGE LYSIN WITH BROAD LYTIC ACTIVITY AGAINST A WIDE RANGE OF
GRAM-POSITIVE PATHOGENS.................................................................................................................................................................83
D. B. Gilmer, J. E. Schmitz, V. A. Fischetti
PHYTOCHEMICAL SCREENING AND ANTIMICROBIAL ACTIVITY OF MIRACLE FRUIT
(SYNSEPALUM DULCIFICUM) AGAINST SIX HUMAN PATHOGEN: POTENTIAL BROADSPECTRUM
ANTIBIOTICS.................................................................................................................................................................................................84
C. I. Munoz, M. L. Delos Santos, M. V. Gojar, L. D. Sagmaquen, T. O. Zulaybar, I. A. Papa
PHELLINSTATIN, A NEW INHIBITOR OF ENOYL-ACP REDUCTASE PRODUCED BY THE MEDICINAL
FUNGUS PHELLINUS LINTEUS.................................................................................................................................................................85
W. Kim, J. Cho, Y. Kwon, M. Sohn, S. Seok
ANTIFUNGAL PROFILE OF COMBRETUM MICRANTHUM G. DON EXTRACTS AGAINST CLINICAL
FUNGAL ISOLATES......................................................................................................................................................................................86
I. P. Udoh, C. I. Eleazar, C. O. Esimone
POLYAMINE EFFECT ON β-LACTAM SUSCEPTIBILITY OF MULTIDRUG RESISTANT
ACINETOBACTER BAUMANNII...............................................................................................................................................................87
L. Malone Jr., D. H. Kwon
ANTI- P. ACNES IN VITRO ACTIVITY OF PROGUANIL....................................................................................................................88
K. C. Godowski, J. Dunham, D. Osborne
ELECTRON MICROSCOPY AND ANTIMICROBIAL EFFECT OF PROTAMINE ON MULTI DRUG
RESISTANT BACTERIA ISOLATED FROM DIABETIC FOOT INFECTION...................................................................................89
M. Aziz, R. Garduno, R. Baqai, S. Kazmi
EFFECTS OF COLD PLASMA ON REDUCTION OF PATHOGENIC ORGANISMS IN A PORCINE WOUND
MODEL.............................................................................................................................................................................................................90
S. C. Davis, J. Gil, A. Claro, S. Hower, G. Fridman, G. Friedman, A. Fridman, L. R. W. Plano

NATURAL PRODUCT SCREENING: GETTING BACK TO OUR “ROOTS” (DIVISION A)

ANTIMICROBIAL ACTIVITY OF COMPOUNDS ISOLATED FROM BRASSICA RAPA AGAINST MULTI-
DRUG RESISTANT BACTERIAL ISOLATES FROM PATIENTS WITH BURN WOUND INFECTION......................................91
F. Samad, S. Faizi, S. Ali, S. U. Kazmi
ANTIMICROBIAL ACTIVITY OF JATROPHA CURCUS ON SEXUALLY TRANSMITTED ORGANISMS..............................92
U. N. Ekwenye, S. A. Aniakor
CULINARY AND MEDICINAL PLANTS AGAINST H.PYLORI INFECTION: NEW HORIZONS IN
THERAPEUTICS.............................................................................................................................................................................................93
S. K. Sherwani, H. H. Abidi, T. R. Siddiqui, S. S. Shakeel S. Akhtar, W. Ahmed, S. U. Kazmi
ESSENTIAL OILS (EOS) AND EO CONSTITUENTS AS ANTIMICROBIALS TOWARD CO-COLONIZING
CF PATHOGENS.............................................................................................................................................................................................94
D. L. Chance, T. P. Mawhinney
ANTIMICROBIAL EFFECT OF A PIGMENT PVP ISOLATED FROM AN ANTARCTIC BACTERIUM ANT
5-2 ON MDR STRAINS OF STAPHYLOCOCCUS AUREUS..................................................................................................................95
J. Huang, N. Mojib, A. Bej
ANTIBACTERIAL ACTIVITY OF THE PROTEIN FRACTIONS OF "B. PINGUIN" FRUIT AND SEED
AGAINST PATHOGEN BACTERIA............................................................................................................................................................96
L. Brito-Argaez, G. Lizama, R. Souza, E. Ortiz
EVALUATION OF THE EFFECT OF ANTIBACTERIAL ACTIVITY OF FLAVONOIDS AND PROTEIN
EXTRACTS OF MELIPONA STINGLESS BEE HONEY........................................................................................................................97
J. Martinez, J. Ramon, D. Chan, L. Cuevas, E. Ortiz
ANTISTAPHYLOCOCCAL ACTIVITY OF ETHANOLIC EXTRACT OF ALCHORNEA CORDIFOLIA LEAF
AGAINST MULTIDRUG RESISTANT STAPHYLOCOCCUS AUREUS..............................................................................................98
G. O. Adeshina, B. O. Olayinka, A. Mohammed, J. A. Onaolapo, Y. K. E. Ibrahim
ANTIMICROBIAL ACTIVITY OF CHEMICALLY SYNTHESIZED CHALCONES.........................................................................99
J. C. Espinoza-Hicks, A. Camacho-Davila, B. E. Rivera-Chavira, G. V. Nevárez-Moorillón
ANTI-HELICOBACTER PYLORI ACTIVITY OF CHINESE CHIVE (ALLIUM TUBEROSUM).................................................100
H. Kudo, H. Takeuchi, T. Shimamura, T. Kashiwagi, T. Sugiura, H. Ukeda
ANTIMICROBIAL ACTIVITY OF CURCUMIN AGAINST VIBRIO VULNIFICUS INFECTION...............................................101
Y. R. Kim, H. S. Na, D-R. Oh, J. H. Rhee
THE CLINICAL EFFICACY OF REFINED DEEP SEAWATER (RDSW) ON COLONIZATION OF
HELICOBACTER PYLORI.........................................................................................................................................................................102
M. Kawada

SALMONELLA: RESISTANCE AND NEW AGENTS (DIVISION A)

HIGH PREVALENCE OF BLACMY AMONG SALMONELLA SEROTYPE HEIDELBERG FROM HUMANS
IN 2009, UNITED STATES...........................................................................................................................................................................103
R. L. Howie, M. Karlsson, G. Pecic, J. Folster, R. Rickert, J. Whichard
ANALYSIS OF ANTIMICROBIAL RESISTANCE AND PLASMID GENES IN MULTIPLE DRUG
RESISTANT (MDR) SALMONELLA ENTERICA ISOLATED FROM ANIMALS AND HUMANS..............................................104
L. M. Glenn, R. L. Lindsey, P. Boerlin, M. W. Gilmour, H. Harbottle, P. J. Fedorka-Cray, J. G. Frye
PLASMID REPLICON TYPING OF HISTORICAL SALMONELLA NEWPORT: 1940-2000........................................................105
A. Singh, S. Zhao, J. L. Sabo, J. W. Abbott, P. I. Fields, P. F. McDermott
INCREASED RESISTANCE TO MULTIPLE ANTIMICROBIALS IN BLA SALMONELLA FOLLOWING
CMY-2
TREATMENT WITH CEFTRIAXONE.....................................................................................................................................................106
R. D. Hamilton, H. J. Hulsebus, S. Akbar, J. T. Gray
MOLECULAR CHARACTERIZATION OF STRAINS OF FLUOROQUINOLONE-RESISTANT
SALMONELLA ENTERICA SEROVAR SCHWARZENGRUND CARRYING MULTIDRUG RESISTANCE
ISOLATED FROM IMPORTED FOODS..................................................................................................................................................107
T. Akiyama, A. A. Khan
SILVER COATED CARBON NANOTUBES MAY INHIBIT SALMONELLA BY DISRUPTION OF THE CELL
MEMBRANE AND CELL WALL...............................................................................................................................................................108
A. S. Hundley, V. K. Rangari, K. Vig, M. Miller, V. A. Dennis, S. R. Singh, S. R. Pillai
GENETIC CHARACTERIZATION OF FLUOROQUINOLONE RESISTANCE GENES OF SALMONELLA
CHOLERAESUIS ISOLATED FROM HUMAN AND PIGS IN TAIWAN...........................................................................................109
Y-M. Hsu, C-Y. Tang, C-C. Chang
TRANSCRIPTIONAL ANALYSIS OF GENES ENCODING REACTIVE OXYGEN SPECIES (ROS)
MEDIATING ENZYMES AS A FUNCTION OF ANTIBIOTIC EXPOSURE IN SALMONELLA ENTERICA
SEROVAR TYPHIMURIUM.......................................................................................................................................................................110
E. Schmidt, H. Tian, C. A. Testa, J. G. Leid, L. Martin, M. Valentine, D. T. Fox, A. T. Koppisch
PROTEOMICS ANALYSIS OF ENVIRONMENTAL SALMONELLA TYPHIMURIUM STRAINS RESISTANT
TO TETRACYCLINE...................................................................................................................................................................................111
Y. Lugo-Melchor, A. P. Barba-De La Rosa, N. Castro-Del Campo, J. León-Félix, M. G. Gaxiola, C. Martínez, C. Chaidez
MOLECULAR ANALYSIS AND DISSEMINATION OF CMY2 PLASMIDS FROM DIVERSE ISOLATES OF
SALMONELLA..............................................................................................................................................................................................112
S. Akbar, H. Hulsebus, J. T. Gray

MECHANISM OF ACTION (DIVISION A)

ANTIMICROBIAL EVALUATION OF A NONPEPTIDIC POLYMER AND ITS INCORPORATION INTO
ANTIMICROBIAL SURGICAL SUTURES..............................................................................................................................................113
K-N. Kumar, Y. Li, R. Scott, K. Nüsslein, G. N. Tew
IN VITRO CHARACTERIZATION OF THE ANTIBACTERIAL PROPERTIES OF SYMMETRIC BIS-
BENZIMIDAZOLES.....................................................................................................................................................................................114
J. B. Moreira, S. Neidle, P. W. Taylor
SYNTHESIS AND EVALUATION OF MICROCIN C ANALOGUES AS POTENTIAL ANTIBIOTICS.......................................115
G. H. M. Vondenhoff, T. Kazakov, J. Rozenski, K. A. Datsenko, B. L. Wanner, K. Severinov, A. Van Aerschot
IN VITRO ANTIMICROBIAL ACTIVITY OF AMINOREDUCTONE AGAINST PATHOGENIC BACTERIA
METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA)............................................................................................116
V. T. Trang, V. H. Son, T. Shimamura, T. Kashiwagi, H. Ukeda, S. Katsuno, T. Sugiura, H. Takeuchi
EFFECT OF STRUCTURAL MODIFICATION OF BERBERINE-INF55 (5-NITRO-2-PHENYLINDOLE)
HYBRID ON ITS ANTIMICROBIAL ACTIVITY...................................................................................................................................117
C. Chen, S. Puri, G. Casadei, N. K. Dolla, M. J. Kelso, K. Lewis
IDENTIFICATION OF THE TARGET PROTEINS OF THE ANTI-VIRULENCE COMPOUNDS, THE
SALICYLIDENE ACYLHYDRAZIDES....................................................................................................................................................118
A. J. Roe, D. Wang, K. S. H. Beckham, M. Gabrielsen, C. E. Zetterstrom, M. Elofsson
THE USE OF LIGHT-ACTIVATED ANTIMICROBIALS TO REDUCE BIOFILM FORMATION ON
CATHETERS.................................................................................................................................................................................................119
J. Pratten, P. Prokopovich, I. P. Parkin, M. Wilson, S. Perni
STRUCTURES OF THIOL PEROXIDASE REVEAL LIKELY BINDING SITES FOR ANTI-VIRULENCE
COMPOUNDS................................................................................................................................................................................................120
K. S. H. Beckham, M. Gabrielsen, O. Byron, A. J. Roe
THERAPEUTIC AND RATIONAL TUNING OF MICROBIAL REACTIVE OXYGEN SPECIES
METABOLISM TO POTENTIATE ANTIMICROBIAL THERAPIES................................................................................................121
J. A. Winkler, M. P. Brynildsen, R. M. Morones, C. Spina, J. J. Collins
TREATMENT OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS BIOFILMS WITH
LYSOSTAPHIN IN A SYNOVIAL FLUID SIMULANT.........................................................................................................................122
J. A. Hobden, B. D. Harrington, V. Dasa
ANTIBIOTIC-POTENTIATING EFFECTS BY NON LETHAL TELLURITE CONCENTRATIONS...........................................123
R. C. Molina, N. D. P. Contreras, C. M. Muñoz, C. C. Vásquez, J. M. Pérez-Donoso
IDENTIFICATION OF BROAD-SPECTRUM ANTI-BIOFILM COMPOUNDS THAT DISRUPT CYCLIC DI-
GMP SIGNALING.........................................................................................................................................................................................124
K. Sambanthamoorthy, V. Parashar, M. Neiditch, C. M. Waters
AN ANTIMICROBIAL PEPTIDE THAT TRAPS DNA INTERMEDIATES ALSO AFFECTS MEMBRANE
INTEGRITY AND INDUCES EFFLUX.....................................................................................................................................................125
I. Naili, J. E. Rostron, A. M. Segall
SMALL NONPEPTIDIC MINICS OF HOST DEFENSE PROTEINS AS POTENTIAL ANTIMALARIAL
DRUGS............................................................................................................................................................................................................126
R. W. Scott, D. C. Greenbaum, M. S. Love, M. G. Millholland, W. F. Degrado, M. J. Costanzo, K. B. Freeman, R. W. Kavash
PRODRUG CANDIDATES FOR THE NEXT BROAD SPECTRUM ANTIMICROBIAL................................................................127
L. Fleck, G. Casadei, J. North, R. Lee, K. Lewis
BETA-LACTAMASE GENES IN MULTI-RESISTANT AEROMONAS SP. ISOLATED FROM RIVER AND
AQUACULTURE WATER SOURCES IN NIGERIA..............................................................................................................................128
C. I. Chikwendu, G. C. Okpokwasili, S. N. Ibe
THE VANADYL RIBONUCLEOSIDE COMPLEX INHIBITS RIBOSOME SYNTHESIS IN ESCHERICHIA
COLI................................................................................................................................................................................................................129
A. D. Frazier, W. S. Champney
SIRTUIN INHIBITION; NAD(+) DEPENDENT HISTONE DEACETYLASE INHIBITION VIA
PYRAZINAMIDE AND 5-CHLOROPYRAZINAMIDE..........................................................................................................................130
J. Seeley, B. Bolivar, S. Alazar, J. T. Welch
LINEZOLID IS SUPERIOR TO VANCOMYCIN FOR THE TREATMENT OF COMMUNITY-ASSOCIATED
MRSA NECROTIZING PNEUMONIA IN A RABBIT MODEL BECAUSE IT SUPPRESSES IN VIVO
PRODUCTION OF PANTON-VALENTINE LEUKOCIDIN AND ALPHA-HEMOLYSIN..............................................................131
A. Afasizheva, H. N. Le, C. Badiou, G. Lina, H. F. Chambers, B. A. Diep
NONPEPTIDIC MIMICS OF HOST DEFENSE PROTEINS AS ANTIMICROBIAL AGENTS FOR
FOODBORNE PATHOGENS......................................................................................................................................................................132
R. W. Scott, S. Mithal, C-Y. Chen
NOVEL INSIGHTS INTO THE EFFECT OF ANTIMICROBIALS ON BACTERIAL PHYSIOLOGY AND
VIABILITY (DIVISION A)

PHYSIOLOGICAL AND MOLECULAR ALTERATIONS IN FUSOBACTERIUM NUCLEATUM EXPOSED
TO SUB-INHIBITORY CONCENTRATIONS OF ANTIMICROBIALS.............................................................................................133
J. A. Souza, N. B. Barbosa, M. S. L. Neves, M. C. R. Freitas, C. M. Coelho, C. G. Diniz, V. L. Silva
FARNESOL CONFERS DRUG TOLERANCE IN CANDIDA ALBICANS.........................................................................................134
M. Rizk, C. Dawson
PHOTODYNAMIC SUB-LETHAL EFFECTS ON GROWTH AND VIABILITY IN E. COLI K12................................................135
R. Bender, R. S. Greene
EFFECT OF PERFLUOROCARBON ON BIOFILM AND PLANKTONIC GROWTH OF PSEUDOMONAS
AERUGINOSA...............................................................................................................................................................................................136
C. B. Irvin, K. E. Cook, M. O. Thornton, A. Satorius, R. Orizondo, J. G. Younger
TRANSCRIPTOME ANALYSIS OF PERSISTER CELLS IN MYCOBACTERIUM TUBERCULOSIS........................................137
I. Keren, E. Rubin, K. Lewis
SMALL MOLECULE MIMICS OF ANTIMICROBIAL PEPTIDES AS POTENT ANTIMALARIALS........................................138
M. G. Millholland, M. S. Love, M. B. Harbut, W. F. Degrado, M. J. Costanzo, K. B. Freeman, R. W. Kavash, R. W. Scott, D. C.
Greenbaum
POTENT ANTIMICROBIAL SMALL MOLECULES SCREENED AS INHIBITORS OF SITE-SPECIFIC
RECOMBINATION AND HOLLIDAY JUNCTION-RESOLVING ENZYMES.................................................................................139
M. C. Rideout, J. L. Boldt, D. K. Ranjit, G. V. Ferguson, P. Salamon, A. Nefzi, J. M. Ostresh, M. Giulianotti, C. Pinilla, A. M.
Segall
IDENTIFICATION AND CHARACTERIZATION OF FOUR INHIBITORS OF TYPE 4 PILUS FORMATION........................141
J. A. Sutherland, T. Ren, S. Chiang, R. K. Taylor
ANALYSIS OF VIRULENCE FACTORS AND ANTIBIOTIC RESISTANCE OF CLINICAL
ENTEROCOCCUS FAECIUM AND E. FAECALIS IN A GERMAN UNIVERSITY HOSPITAL...................................................142
R. F. W. Ebbeler, S. Joergens, B. Ghebremedhin

CATEGORY AA – FREE-LIVING, SYMBIOTIC, AND PARASITIC PROTISTS

FREE-LIVING, SYMBIOTIC AND PARASITIC PROTISTS (DIVISION AA)

A DOC2 PROTEIN IDENTIFIED BY MUTATIONAL PROFILING IS ESSENTIAL FOR APICOMPLEXAN
PARASITE MICRONEME SECRETION..................................................................................................................................................143
S. Thirugnanam, A. Farrell, A. Lorestani, J. D. Dvorin, K. P. Eidell, B. R. Anderson-White, M. T. Duraisingh, G. T. Marth, M-J. J.
Gubbels
MOLECULAR ANALYSIS AND STRUCTURAL MODELING OF GLUTATHIONE S-TRANSFERASE OF
PLASMODIUM BERGHEI..........................................................................................................................................................................144
E. E. Colón-Lorenzo, R. González-Méndez, A. E. Serrano
EXCRETORY-SECRETORY PROTEINS OF GIARDIA LAMBLIA INDUCE INTERLEUKIN-8
PRODUCTION FROM HUMAN INTESTINAL CELLS, HT-29 CELLS VIA ACTIVATION OF P38 AND ERK
1/2 MAPKS, AND NF-ĸB, AP-1, AND C/EBP............................................................................................................................................145
H-Y. Lee, T-S. Yong, S-J. Park
GIARDIA FLAGELLAR MOTILITY IS NECESSARY FOR CELLULAR POSITIONING, BUT IS NOT
DIRECTLY REQUIRED FOR MAINTAINED ATTACHMENT..........................................................................................................146
S. A. House, J. K. Pham, D. Richter, S. C. Dawson
THE ROLE OF KEY IMC PROTEINS IN TOXOPLASMA GONDII CYTOSKELETAL DEVELOPMENT...............................147
B. R. Anderson-White, A. Kosber, M-J. Gubbels
ASSESSMENT OF CRYOPROTECTANT TOXICITY ON THE VIABILITY OF CRYPTOSPORIDIUM
PARVUM........................................................................................................................................................................................................148
K. C. Glaser, R. E. Molestina
ALL TRANSCRIPTS ARE DEGRADED EQUAL: LACK OF DISCRIMINATION IN MRNA DECAY IN
GIARDIA LAMBLIA....................................................................................................................................................................................149
C. Williams, H. Elmendorf
REGULATION OF TRANSLATION BY A MOLECULAR SCAFFOLD PROTEIN IN LEISHMANIA........................................150
B. L. Kelly
MOSQUITO-BACTERIA SYMBIOSIS......................................................................................................................................................151
E. R. Derbyshire, G. Carr, J. Clardy
A MUTS HOMOLOG IS PART OF A DRUG-INDUCIBLE DEATH PATHWAY IN THE PARASITE
TOXOPLASMA GONDII.............................................................................................................................................................................152
G. Arrizabalaga, E. M. Garrison, M. Lavine
DISRUPTION OF AUTOGAMY IN PARAMECIUM USING INHIBITORS OF APOPTOSIS AND
AUTOPHAGY................................................................................................................................................................................................153
W. E. Bell, C. John
TRICHOMONAS VAGINALIS RHOMBOIDS; A GLIMPSE FROM GENOMIC AND EXPRESSION
ANALYSIS......................................................................................................................................................................................................154
H. Hernandez, A. S. Kucknoor
A STRUCTURE BASED DRUG DESIGN APPROACH TO REPURPOSE DRUGS AGAINST PLASMODIUM
FALCIPARUM HSP90 (PFHSP90).............................................................................................................................................................155
D. Shahinas, M. Liang, R. Lau, T. Taldone, G. Chiosis, I. Crandall, D. R. Pillai
EFFECT OF OXABOROLE COMPOUNDS ON POLYAMINE METABOLISM IN TRYPANOSOMES......................................156
E. Paul, M. Morada, D. Rattendi, B. Nare, R. Jacobs, C. Cyrus Bacchi, R. Don, N. Yarlett

CATEGORY B – MICROBIAL PATHOGENS

REGULATION OF VIRULENCE I (DIVISION B)

TEMPERATURE-DEPENDENT REGULATION OF SHIGELLA DYSENTERIAE SHUA EXPRESSION..................................157
A. B. Kouse, E. R. Murphy
SHIGELLA DYSENTERIAE RYHB AFFECTS VIRB TRANSCRIPTION.........................................................................................158
W. Broach, E. R. Murphy
GACA AND THE IRON RESPONSE IN V. VULNIFICUS.....................................................................................................................159
R. A. Swain, M. K. Jones, P. A. Gulig, A. C. Wright
CHARACTERIZATION AND GENE REGULATION OF AN OXYR-LIKE PROTEIN IN
CORYNEBACTERIUM DIPHTHERIAE..................................................................................................................................................160
P. L. Rossi, D. M. Oram
TYPE 1 PILI EXPRESSION CANNOT RESCUE IN VIVO PERSISTENCE OF A UROPATHOGENIC
ESCHERICHIA COLI STRAIN CARRYING A QSEC DELETION.....................................................................................................161
M. Kostakioti, M. Hadjifrangiskou, C. K. Cusumano, S. J. Hultgren
UTILIZATION OF A LAC REPRESSOR/OPERATOR SYSTEM TO GENERATE A CONDITIONAL
MUTANT IN THE RRP2 RESPONSE REGULATOR OF THE LYME DISEASE SPIROCHETE, BORRELIA
BURGDORFERI............................................................................................................................................................................................162
A. Groshong, X. F. Yang, J. Blevins
CODY LINKS METABOLISM AND VIRULENCE IN STAPHYLOCOCCUS AUREUS.................................................................163
A. E. Roux, C. D. Majerczyk, A. L. Sonenshein
THE RPOE REGULON IN NONTYPEABLE HAEMOPHILUS INFLUENZAE................................................................................164
B. D. Baker, A. Harrison, D. L. Newsom, P. White, R. S. Munson Jr.
RELATIONSHIP BETWEEN PSEUDOMONAS AERUGINOSA BIOFILM DISPERSION AND
PATHOGENICITY IN THE ANIMAL HOST MODEL CAENORHABDITIS ELEGANS................................................................165
B-Y. Hong, H. Lee, K. Sauer, D. G. Davies
CHARACTERIZATION OF THE SMALL RNA SRAB IN SHIGELLA DYSENTERIAE................................................................166
E. Almasude, E. R. Murphy
A PROKARYOTIC UBIQUITIN-LIKE PROTEIN SYSTEM IN CORYNEBACTERIUM DIPHTHERIAE.................................167
F. Jobling, R. K. Holmes
EFFECT OF CULTURE TEMPERATURE ON EXPRESSION OF EXTRACELLULAR PROTEINS
PRODUCED BY STAPHYLOCOCCUS AUREUS...................................................................................................................................168
K. Seo, G. Bohach
IDENTIFICATION OF OLIGONUCLEOTIDES AND A PROTEIN PHYSICALLY BOUND BY CYCLO-PHE-
PRO (CFP) IN VIBRIO VULNIFICUS.......................................................................................................................................................169
J-S. Son, I. Kim, A. Jo, B-H. Lee, S-H. Choi, W. Lee, K-S. Kim
DISTINCT ROLES OF THE P1 AND P3 PROMOTERS IN SIGNALING OF THE SAERS TWO COMPONENT
SYSTEM IN STAPHYLOCOCCUS AUREUS..........................................................................................................................................170
D-W. Jeong, H. Cho, C. Li, T. Bae
OMPR REGULATION OF THE UROPATHOGENIC ESCHERICHIA COLI FIMB GENE...........................................................171
A. Rentschler, S. D. Lovrich, W. R. Schwan
THE REGULATORY NETWORK CONTROLLING ZINC INHIBITION OF THE LEE OF
ENTEROPATHOGENIC ESCHERICHIA COLI.....................................................................................................................................172
M. Turvey, K. Thomas, J. Crane, E. Boedeker, J. Mellies
SUPPRESSION OF ALGINATE PRODUCTION IN PSEUDOMONAS AERUGINOSA WITH WILD-TYPE
MUCA..............................................................................................................................................................................................................173
T. R. Withers, H. D. Yu
THE ROLE OF QUINONES IN ENTEROHEMORRHAGIC E. COLI (EHEC) VIRULENCE........................................................174
M. M. Curtis, V. Sperandio
IDENTIFYING QUORUM SENSING PHEROMONES THAT REGULATE VIRULENCE IN
STREPTOCCOCUS PYOGENES...............................................................................................................................................................175
C. Aggarwal, M. J. Federle
DELETION OF GLUCOSE-INHIBITED DIVISION GENE (GIDA) ALTERS THE IN VIVO VIRULENCE
CHARACTERISTICS OF SALMONELLA ENTERICA SEROVAR TYPHIMURIUM....................................................................176
D. C. Shippy, N. M. Eakley, P. N. Bochsler, A. A. Fadl
THE EFFECTS OF FEVER TEMPERATURE ON GENE EXPRESSION IN ESCHERICHIA COLI............................................177
G. Y. Nendah, C. A. White-Ziegler
GROUP A STREPTOCOCCUS RESPONSES TO PEROXIDE STRESS.............................................................................................178
R. Grifantini, C. Toukoki, A. Colaprico, I. Gryllos